Manipal Health Q1FY27 results due Aug 20, 2026

Stock trades lower ahead of results

Manipal Health Enterprises Ltd. was trading at Rs 724.35 on 20 Aug, 2026 (10:30 AM IST), after falling 2.75% from the previous close of Rs 744.80. The move came on a day when the company had scheduled a board meeting to consider and approve its quarterly financial results. Market benchmarks were also in the red at the time, with Sensex at 78,499.17 (-455.59) and Nifty at 24,570.65 (-65.35).

Market data shown alongside the quote included a Bid/Ask of 743.00 / 744.50. Separately, another quote snapshot for the same date showed ₹727.7 (-2.30%) with a timestamp of Aug 20, 2026 | 08:39:56 PM, indicating different points in the trading day.

Board meeting: Q1FY27 unaudited results agenda

The company informed the BSE that the meeting of its Board of Directors is scheduled on 20/08/2026 to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter ended June 30, 2026. The disclosure was positioned as a “Board Meeting Intimation” and explicitly referenced the quarterly results approval as the purpose.

The meeting and results announcement are being tracked as a key near-term event for investors following the company’s recent public-market listing.

Earnings call on August 21: management participants and timing

Following the results, the management team is set to host an earnings conference call on Friday, August 21, 2026, scheduled from 11:00 am to 12:00 pm IST. The call is intended to discuss the financial performance for the quarter ended June 30, 2026.

The company stated that the conference call is scheduled under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It also noted that the company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the event on August 17, 2026.

Named participants for the call include:

• Dilip Jose, Managing Director and Chief Executive Officer
• Sameer Agarwal, Chief Financial Officer
• Karthik Rajagopal, Chief Operating Officer

Dial-in details and DiamondPass pre-registration

Investors and analysts were provided dial-in details for the earnings call. The company also advised participants to pre-register using the DiamondPass facility to avoid long queues.

Recent corporate and listing context

The stock’s current trading levels are being watched in the context of its recent listing. Information provided showed:

• Listed on: 5 Aug ’26
• Issue price: ₹590.00
• Listing price: ₹652.00
• Listing gains: ₹62.00 (10.51%)

There was also a separate line stating: “Manipal Health Enterprises is set to list its Rs 9,275.22 crore mainboard IPO on the BSE and NSE on August 5,” reflecting pre-listing positioning in the same information set.

In addition, the company’s IPO details were presented as:

• IPO open date: 29 Jul 2026
• IPO close date: 31 Jul 2026
• Allotment date: 3 Aug 2026
• Funds unblock or debit: 5 Aug 2026
• Issue size: ₹9,275.22 crore
• Lot size: 25
• Price range: ₹560 – ₹590

IPO proceeds: stated uses of funds

The information set also included a table of estimated IPO proceeds deployment (₹ crore). Two disclosed items were:

• ₹5,378.00 crore for repayment or prepayment (in full or in part) of certain outstanding borrowings and accrued interest availed by a material subsidiary, Manipal Hospitals Private Limited.
• ₹574.00 crore for acquisition of minority stake in the stepdown subsidiary, Sahyadri Hospitals Private Limited.

Financial snapshot: profit and loss and margins

Consolidated profit and loss figures (₹ crore) were provided for multiple financial years ending March:

• Revenue line (as displayed): ₹1,813 (Mar 2021), ₹3,975 (Mar 2022), ₹4,806 (Mar 2023), ₹6,172 (Mar 2024), ₹8,242 (Mar 2025), ₹10,336 (Mar 2026).
• Operating profit: ₹330 (Mar 2021) to ₹2,611 (Mar 2026).
• Operating margin (OPM %): 18% (Mar 2021), 23% (Mar 2022), 27% (Mar 2023), 27% (Mar 2024), 26% (Mar 2025), 25% (Mar 2026).

Half-yearly consolidated figures (₹ crore) for Sep 2025 were also shown, including:

• Revenue line (as displayed): ₹4,713
• Operating profit: ₹1,258
• OPM %: 27%
• Profit before tax: ₹762
• Tax %: 25%
• Profit after tax line (as displayed): ₹572
• EPS in Rs: 4.86

Key market metrics shown with the stock

A separate market snapshot associated with the stock included:

• Market Cap: ₹92,991 crore
• Stock P/E: 103
• Dividend Yield: 0.00%
• ROCE: 12.1%
• ROE: 12.7%
• High / Low: ₹717 / ₹625

These metrics were displayed alongside a “current price” point of ₹707 in the same snapshot, indicating they may relate to a particular date view rather than the intraday quote of ₹724.35.

Other disclosures referenced

One disclosure line stated: Deutsche Bank disclosed encumbrance over 21.5% of Manipal Health Enterprises shares on August 5, 2026. The same information set also listed identifiers including BSE: 544847, NSE: MANIPALHOSEQ, and ISIN: INE459N01021.

Company contact and registered address

The company’s registered office and contact information were provided as:

• Registered Office: The Annexe, #98/2, Rustom Bagh, HAL Airport Road, Bengaluru 560 017, Karnataka, India
• Email: legalcs@manipalhospitals.com
• Website: www.manipalhospitals.com

What to watch next

The immediate focus is the board meeting on August 20, 2026 to approve the Q1FY27 unaudited standalone and consolidated results for the quarter ended June 30, 2026. The follow-up earnings call on August 21, 2026 (11:00 am IST) is the next scheduled event, with the MD and CEO, CFO, and COO listed as participants.